市場調査レポート

商品コード

1781183

動物用薬剤感受性検査の世界市場、動物タイプ別、製品タイプ別、エンドユーザー別、地域別、機会、予測、2018年～2032年

Global Veterinary Antimicrobial Susceptibility Testing Market Assessment, By Animal Type, By Product, By End-user, By Region, Opportunities and Forecast, 2018-2032F

出版日: 2025年08月01日
発行: Markets & Data
ページ情報: 英文 237 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,800 711,648円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 6,000 889,560円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,500 1,260,210円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=148.26円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の動物用薬剤感受性検査市場は、予測期間2025-2032年にCAGR 5.61%を記録し、2024年の11億1,000万米ドルから2032年には17億2,000万米ドルに成長すると予測されています。この市場の主な原動力は、主要な獣医組織における規制およびトレーニングイニシアチブの高まり、抗菌薬感受性試験（AST）における人工知能（AI）の可能性の高まり、家畜頭数の増加、動物間の抗菌薬耐性（AMR）の増加などの要因です。

世界の動物用薬剤感受性検査（AST）市場は、動物の抗菌薬耐性問題の高まりと正しい抗生物質投与に関する意識の拡大により、着実に成長しています。ASTのプロセスは、家畜とコンパニオンアニマルの両方で適切な細菌感染治療を選択するために獣医専門家に不可欠な情報を提供し、抗菌薬の誤用を減らします。この方法は、動物の健康と人間の健康および環境の健康との間に強い結びつきを確立することにより、世界のOne Healthの原則に従っています。獣医学的診断分野は、規制の厳格化と獣医専門家およびASTサービスを求めるペット所有者の意識の高まりにより成長を遂げています。動物用標準検査室は、診療所や病院とともに、治療の成功率を高め、抗菌薬耐性を防止するための標準診断手順としてAST検査を使用しています。迅速な診断アプローチや人工知能評価システムとともに自動検査装置を導入することで、検査手順の精度とスピードが向上しています。市場は、獣医療施設が発展し続ける一方で、相当数の動物が飼育されている地域で強さを増しています。市場は、抗菌薬スチュワードシップを奨励する政府のプログラムや、獣医ヘルスケアへの資金援助を通じて拡大しています。獣医用AST市場は、高価な検査や地方での検査制限などの障害に直面しているもの、規制の枠組みや世界の健康目標とともに技術の進歩があるため、将来的に力強い成長の可能性を示しています。

例えば、2023年9月、FAOモンゴルは、残留抗生物質と抗菌剤耐性を検出するために、21の州で50人以上の獣医検査アナリストを訓練しました。この研修は、実践的かつ理論に基づいた学習を通じて食品安全と公衆衛生を強化することを目的としたACTおよびMPTFプロジェクトの一環として実施されました。このようなプログラムは、動物用薬剤感受性検査市場の需要を押し上げます。

市場規模分析と予測
- 金額別
市場シェア分析と予測
- 動物タイプ別
  - 生産
  - コンパニオン
- 製品別
  - アクセサリと消耗品
  - 自動化AST機器
  - 細胞培養培地
  - ディスクとプレート
- エンドユーザー別
  - 獣医リファレンスラボ
  - 獣医調査機関
  - その他
- 地域別
  - 北米
  - 欧州
  - アジア太平洋
  - 南米
  - 中東・アフリカ
- 企業別市場シェア分析（上位5社およびその他- 金額別、2024年）
2024年市場マップ分析
- 動物タイプ別
- 製品別
- エンドユーザー別
- 地域別

第6章北米の動物用薬剤感受性検査市場の展望、2018年～2032年

市場規模分析と予測
- 金額別
市場シェア分析と予測
- 動物タイプ別
  - 生産
  - コンパニオン
- 製品別
  - アクセサリと消耗品
  - 自動化AST機器
  - 細胞培養培地
  - ディスクとプレート
- エンドユーザー別
  - 獣医リファレンスラボ
  - 獣医調査機関
  - その他
- 国別シェア
  - 米国
  - カナダ
  - メキシコ
国別市場評価
- 米国の動物用薬剤感受性検査市場の展望、2018年～2032年
  - 市場規模分析と予測
  - 市場シェア分析と予測
- カナダ
- メキシコ

すべてのセグメントは、対象となるすべての地域と国に提供されます。

第7章欧州の動物用薬剤感受性検査市場の展望、2018年～2032年

ドイツ
フランス
イタリア
英国
ロシア
オランダ
スペイン
トルコ
ポーランド

第8章アジア太平洋の動物用薬剤感受性検査市場の展望、2018年～2032年

インド
中国
日本
オーストラリア
ベトナム
韓国
インドネシア
フィリピン

第9章南米の動物用薬剤感受性検査市場の展望、2018年～2032年

ブラジル
アルゼンチン

第10章中東・アフリカの動物用薬剤感受性検査市場の展望、2018年～2032年

サウジアラビア
アラブ首長国連邦
南アフリカ

第11章バリューチェーン分析

第12章ポーターのファイブフォース分析

第13章 PESTLE分析

第14章価格分析

第15章市場力学

市場促進要因
市場の課題

第16章市場動向と発展

第17章ケーススタディ

第18章競合情勢

市場リーダー上位5社の競合マトリックス
トップ5企業のSWOT分析
市場トップ10の主要企業の情勢
- BioMerieux SA
- Becton, Dickinson and Company
- Synoptics Group
- Thermo Fisher Scientific, Inc.
- Bruker Corporation
- Danaher Corporation
- Laboratorios Conda, SA
- Bioguard Corporation
- Liofilchem Srl
- Bio-Rad Laboratories, Inc.

上記の企業は市場シェアに応じて注文を保留するものではなく、調査作業中に入手可能な情報に応じて変更される可能性があります。

第19章戦略的提言

第20章調査会社について・免責事項

図表

List of Tables

Table 1. Competition Matrix of Top 5 Market Leaders
Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 2. Global Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 3. Global Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 4. Global Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 5. Global Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Region, 2018-2032F
Figure 6. North America Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 7. North America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 8. North America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 9. North America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 10. North America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Country, 2018-2032F
Figure 11. United States Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 12. United States Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 13. United States Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 14. United States Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 15. Canada Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 16. Canada Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 17. Canada Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 18. Canada Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 19. Mexico Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 20. Mexico Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 21. Mexico Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 22. Mexico Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 23. Europe Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 24. Europe Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 25. Europe Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 26. Europe Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 27. Europe Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Country, 2018-2032F
Figure 28. Germany Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 29. Germany Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 30. Germany Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 31. Germany Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 32. France Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 33. France Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 34. France Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 35. France Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 36. Italy Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 37. Italy Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 38. Italy Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 39. Italy Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 40. United Kingdom Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 41. United Kingdom Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 42. United Kingdom Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 43. United Kingdom Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 44. Russia Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 45. Russia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 46. Russia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 47. Russia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 48. Netherlands Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 49. Netherlands Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 50. Netherlands Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 51. Netherlands Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 52. Spain Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 53. Spain Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 54. Spain Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 55. Spain Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 56. Turkey Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 57. Turkey Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 58. Turkey Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 59. Turkey Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 60. Poland Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 61. Poland Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 62. Poland Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 63. Poland Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 64. South America Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 65. South America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 66. South America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 67. South America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 68. South America Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Country, 2018-2032F
Figure 69. Brazil Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 70. Brazil Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 71. Brazil Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 72. Brazil Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 73. Argentina Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 74. Argentina Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 75. Argentina Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 76. Argentina Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 77. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 78. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 79. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 80. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 81. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Country, 2018-2032F
Figure 82. India Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 83. India Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 84. India Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 85. India Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 86. China Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 87. China Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 88. China Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 89. China Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 90. Japan Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 91. Japan Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 92. Japan Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 93. Japan Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 94. Australia Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 95. Australia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 96. Australia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 97. Australia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 98. Vietnam Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 99. Vietnam Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 100. Vietnam Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 101. Vietnam Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 102. South Korea Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 103. South Korea Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 104. South Korea Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 105. South Korea Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 106. Indonesia Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 107. Indonesia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 108. Indonesia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 109. Indonesia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 110. Philippines Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 111. Philippines Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 112. Philippines Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 113. Philippines Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 114. Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 115. Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 116. Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 117. Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 118. Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Country, 2018-2032F
Figure 119. Saudi Arabia Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 120. Saudi Arabia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 121. Saudi Arabia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 122. Saudi Arabia Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 123. UAE Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 124. UAE Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 125. UAE Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 126. UAE Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 127. South Africa Veterinary Antimicrobial Susceptibility Testing Market, By Value, In USD Billion, 2018-2032F
Figure 128. South Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Animal Type, 2018-2032F
Figure 129. South Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By Product, 2018-2032F
Figure 130. South Africa Veterinary Antimicrobial Susceptibility Testing Market Share (%), By End-user, 2018-2032F
Figure 131. By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 132. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 133. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2024
Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024

Product Code: MX13841

Global veterinary antimicrobial susceptibility testing market is projected to witness a CAGR of 5.61% during the forecast period 2025-2032, growing from USD 1.11 billion in 2024 to USD 1.72 billion in 2032. The market is primarily driven by factors like rising regulatory and training initiatives among leading veterinary organizations, the growing potential of artificial intelligence (AI) in antimicrobial susceptibility testing (AST), the rising livestock population, and growing antimicrobial resistance (AMR) among animals.

Global veterinary antimicrobial susceptibility testing (AST) market is growing steadily because of rising animal antimicrobial resistance issues and expanding awareness about correct antibiotic practices. The process of AST provides essential information for veterinary professionals to select proper bacterial infection treatments in both livestock and companion animals, which reduces antimicrobial misuse. The method follows worldwide One Health principles by establishing strong links between animal health and human health and environmental health. The veterinary diagnostic sector experiences growth because of stricter regulations and rising awareness among veterinary professionals and pet owners who seek AST services. Veterinary reference laboratories, together with clinics and hospitals, use AST testing as a standard diagnostic procedure to improve treatment success rates and prevent antimicrobial resistance. The implementation of automated testing devices along with quick diagnostic approaches and artificial intelligence evaluation systems has enhanced the precision and speed of testing procedures. The market shows increasing strength in regions that maintain substantial animal numbers while veterinary facilities continue to develop. The market expands through government programs that encourage antimicrobial stewardship and veterinary healthcare funding. The veterinary AST market demonstrates robust future growth potential because of technological advancements alongside regulatory frameworks and worldwide health objectives, although it faces obstacles from expensive testing and rural testing restrictions.

For instance, in September 2023, FAO Mongolia trained over 50 veterinary laboratory analysts in 21 provinces to detect antibiotic residues and antimicrobial resistance. The training is identified as part of the ACT and MPTF projects, intended to strengthen food safety and public health through practical and theory-based learning. Such programs boost the demand for the veterinary antimicrobial susceptibility testing market.

Rising Prevalence of Antimicrobial Resistance Boosts Market Demand

The increasing occurrence of antimicrobial resistance (AMR) in animals represents a primary factor that escalates the need for veterinary antimicrobial susceptibility testing (AST). Excessive and incorrect use of antibiotics in livestock and companion animals has produced bacteria that resist treatment, leading to difficult medical interventions and increased disease transmission potential. The increasing resistance of pathogens endangers animal well-being and generates major public health threats because these resistant pathogens can reach humans through direct animal interactions or food consumption. Veterinary AST enables veterinarians to select the best antimicrobial drugs that specifically address certain infections, thus providing them with data to deliver precise treatments. Veterinary professionals together with farmers and pet owners and regulatory agencies, now focus more heavily on responsible antibiotic practices because of their growing awareness of AMR. Stewardship programs mandated or suggested by governments and international health organizations require veterinary providers to conduct AST before making antibiotic prescriptions. The new medical approach has led to a substantial rise in the adoption of AST services which drives overall market expansion.

For instance, in February 2024, Avails Medical secured FDA 510(k) clearance for the eQUANT system, a rapid, automated device for antibiotic susceptibility testing. eQUANT standardizes the inoculum from positive blood cultures such that it reduces routine AST turnaround times by as much as one day and facilitates earlier and more effective targeted antibiotic therapy.

Technological Advancement in Diagnostic Testing Fuels Market Growth

Technological advancements in diagnostics are certainly propelling growth in the veterinary antimicrobial susceptibility testing (AST) market. The traditional manual testing approach works effectively but requires extensive time and causes human mistakes to occur. Modern diagnostic technologies, including automated AST systems as well as microfluidic devices and rapid molecular assays, and AI-powered platforms, produce fast, precise, and dependable testing outcomes. The new technologies enable veterinary professionals and diagnostic labs to detect pathogens quickly while determining optimal antimicrobial agents, which leads to precise and prompt treatment choices. Automated processes decrease work intensity while producing consistent outcomes, and microfluidics combined with PCR-based methods transform diagnostic turnaround times from multiple days to a few hours. The advanced diagnostic systems offer the ability to detect multiple resistance genes simultaneously within a single test, which improves the overall testing efficiency. The integration of AI technology enables data interpretation, trend analysis, and surveillance reporting, which leads to more accessible and actionable diagnostics. Veterinary practices and reference labs requiring improved productivity and antimicrobial stewardship guideline compliance drive the growing demand for advanced diagnostic tools, which expands the AST market worldwide.

For instance, in June 2023, Sysmex Corporation released a ground-breaking point-of-care system for the rapid antimicrobial susceptibility testing of urine samples in only 30 minutes in Europe. This innovation tackles urinary tract infections while supporting infection control for reducing antimicrobial resistance in clinical settings.

Veterinary Reference Laboratory Holds Largest Market Share

The veterinary antimicrobial susceptibility testing (AST) market shows its largest market share in veterinary reference laboratories because they maintain advanced infrastructure and handle high testing volumes while serving as diagnostic hubs. These laboratories maintain high-throughput automated testing systems that deliver precise and rapid antimicrobial testing for all animal species. The laboratories serve veterinary clinics, hospitals, farms, and academic institutions through large diagnostic sample processing while implementing standard testing protocols. The laboratories receive complex cases for processing while participating in antimicrobial resistance surveillance programs and delivering fast turnaround times, thus making them the preferred providers of AST services. Reference labs maintain strict quality control standards and employ skilled personnel, which results in producing reliable results. In addition, partnerships with regulators and researchers put them in an advantageous position in antimicrobial stewardship. As antibiotic therapies that target diseases increase in demand, veterinary reference laboratories continue to take the lead in both services rendered and technology adoption.

North America Dominates the Veterinary Antimicrobial Susceptibility Testing Market

North America holds a dominant position in the veterinary antimicrobial susceptibility testing (AST) market because of its superior animal health facilities, together with its robust regulatory system. The area has a relatively high level of awareness of antimicrobial resistance and the significance of targeted antibiotic use among veterinarians and animal health professionals. This high level of awareness has resulted in an increased adoption of AST in veterinary and consultant veterinary clinics, hospitals, and reference laboratories. The United States leads the market through its established surveillance networks and government antimicrobial stewardship programs, and funding for diagnostic technology development. The FDA and USDA use regulatory frameworks to advance animal antibiotic stewardship by pushing veterinary professionals toward AST testing for treatment decisions. The market receives additional support from the expanding pet population, together with growing livestock operations and rising animal health expenditures.

For instance, in January 2024, the American Veterinary Medical Association (AVMA) released six documents on animal antimicrobial susceptibility testing, providing veterinary professionals with guidance on selecting antimicrobial therapy and predicting outcomes for a range of antimicrobial agents in bacterial infections.

Impact of U.S. Tariffs on Veterinary Antimicrobial Susceptibility Testing Market

The veterinary antimicrobial susceptibility testing market faces substantial effects from U.S. tariffs on diagnostic equipment and raw materials imported from manufacturing centers, including China. Tariffs lead to increased prices of crucial instruments, together with consumables such as culture media, along with testing panels and automated systems that need importing.

The increased costs may affect veterinary clinics, together with laboratories and end-users, by decreasing the usage of advanced AST technologies, especially in practices with limited budgets. Veterinary facilities with limited resources may postpone their equipment replacements or choose manual testing methods, which result in decreased diagnostic precision and longer testing periods.

Trade policy uncertainties create supply chain disruptions, which cause inventory shortages and restrict access to premium testing components. Domestic production growth may occur as a reaction to tariffs, but it does not immediately balance out the shortfall or pricing effects.

The implementation of tariffs creates financial obstacles that could hold back market growth and slow down technological adoption in the United States' veterinary antimicrobial susceptibility testing systems.

Key Players Landscape and Outlook

The competitive landscape of the veterinary antimicrobial susceptibility market is characterized by innovation along with worldwide expansion and strategic partnerships. The main players develop modern diagnostic technologies that include automated systems and rapid molecular assays to improve both speed and precision of their testing processes. R&D investments, along with partnerships between research institutions and veterinary organizations, help these companies build stronger market positions. Their growth strategies depend on entering developing markets and providing affordable and scalable solutions. The market will experience increased competition because companies strive to meet growing demand which stems from worldwide antimicrobial resistance issues and regulatory requirements.

In June 2023, bioMerieux SA earned nine clinical laboratory IMV ServiceTrak awards, a significant achievement. These awards recognized the company's excellence across five markets, including Immunoassay, ID/AST, and Blood Culture, further underscoring its commitment to high-quality diagnostics solutions and its leadership position in the clinical laboratory market.

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Global Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
5.2. Market Share Analysis & Forecast
- 5.2.1. By Animal Type
  - 5.2.1.1. Production
  - 5.2.1.2. Companion
- 5.2.2. By Product
  - 5.2.2.1. Accessories and Consumables
  - 5.2.2.2. Automated AST Instruments
  - 5.2.2.3. Culture Media
  - 5.2.2.4. Disks and Plates
- 5.2.3. By End-user
  - 5.2.3.1. Veterinary Reference Lab
  - 5.2.3.2. Vet Research Institutes
  - 5.2.3.3. Others
- 5.2.4. By Region
  - 5.2.4.1. North America
  - 5.2.4.2. Europe
  - 5.2.4.3. Asia-Pacific
  - 5.2.4.4. South America
  - 5.2.4.5. Middle East and Africa
- 5.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
5.3. Market Map Analysis, 2024
- 5.3.1. By Animal Type
- 5.3.2. By Product
- 5.3.3. By End-user
- 5.3.4. By Region

6. North America Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

6.1. Market Size Analysis & Forecast
- 6.1.1. By Value
6.2. Market Share Analysis & Forecast
- 6.2.1. By Animal Type
  - 6.2.1.1. Production
  - 6.2.1.2. Companion
- 6.2.2. By Product
  - 6.2.2.1. Accessories and Consumables
  - 6.2.2.2. Automated AST Instruments
  - 6.2.2.3. Culture Media
  - 6.2.2.4. Disks and Plates
- 6.2.3. By End-user
  - 6.2.3.1. Veterinary Reference Lab
  - 6.2.3.2. Vet Research Institutes
  - 6.2.3.3. Others
- 6.2.4. By Country Share
  - 6.2.4.1. United States
  - 6.2.4.2. Canada
  - 6.2.4.3. Mexico
6.3. Country Market Assessment
- 6.3.1. United States Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F*
  - 6.3.1.1. Market Size Analysis & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share Analysis & Forecast
    - 6.3.1.2.1. By Animal Type
      - 6.3.1.2.1.1. Production
      - 6.3.1.2.1.2. Companion
    - 6.3.1.2.2. By Product
      - 6.3.1.2.2.1. Accessories and Consumables
      - 6.3.1.2.2.2. Automated AST Instruments
      - 6.3.1.2.2.3. Culture Media
      - 6.3.1.2.2.4. Disks and Plates
    - 6.3.1.2.3. By End-user
      - 6.3.1.2.3.1. Veterinary Reference Lab
      - 6.3.1.2.3.2. Vet Research Institutes
      - 6.3.1.2.3.3. Others
- 6.3.2. Canada
- 6.3.3. Mexico

All segments will be provided for all regions and countries covered

7. Europe Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

7.1. Germany
7.2. France
7.3. Italy
7.4. United Kingdom
7.5. Russia
7.6. Netherlands
7.7. Spain
7.8. Turkey
7.9. Poland

8. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

8.1. India
8.2. China
8.3. Japan
8.4. Australia
8.5. Vietnam
8.6. South Korea
8.7. Indonesia
8.8. Philippines

9. South America Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

9.1. Brazil
9.2. Argentina

10. Middle East and Africa Veterinary Antimicrobial Susceptibility Testing Market Outlook, 2018-2032F

10.1. Saudi Arabia
10.2. UAE
10.3. South Africa

11. Value Chain Analysis

12. Porter's Five Forces Analysis

13. PESTLE Analysis

14. Pricing Analysis

15. Market Dynamics

15.1. Market Drivers
15.2. Market Challenges

16. Market Trends and Developments

17. Case Studies

18. Competitive Landscape

18.1. Competition Matrix of Top 5 Market Leaders
18.2. SWOT Analysis for Top 5 Players
18.3. Key Players Landscape for Top 10 Market Players
- 18.3.1. BioMerieux SA
  - 18.3.1.1. Company Details
  - 18.3.1.2. Key Management Personnel
  - 18.3.1.3. Products and Services
  - 18.3.1.4. Financials (As Reported)
  - 18.3.1.5. Key Market Focus and Geographical Presence
  - 18.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
- 18.3.2. Becton, Dickinson and Company
- 18.3.3. Synoptics Group
- 18.3.4. Thermo Fisher Scientific, Inc.
- 18.3.5. Bruker Corporation
- 18.3.6. Danaher Corporation
- 18.3.7. Laboratorios Conda, S.A.
- 18.3.8. Bioguard Corporation
- 18.3.9. Liofilchem S.r.l.
- 18.3.10. Bio-Rad Laboratories, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

動物用薬剤感受性検査の世界市場、動物タイプ別、製品タイプ別、エンドユーザー別、地域別、機会、予測、2018年～2032年

Global Veterinary Antimicrobial Susceptibility Testing Market Assessment, By Animal Type, By Product, By End-user, By Region, Opportunities and Forecast, 2018-2032F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 世界の動物用薬剤感受性検査市場の展望、2018年～2032年

第6章 北米の動物用薬剤感受性検査市場の展望、2018年～2032年

第7章 欧州の動物用薬剤感受性検査市場の展望、2018年～2032年

第8章 アジア太平洋の動物用薬剤感受性検査市場の展望、2018年～2032年

第9章 南米の動物用薬剤感受性検査市場の展望、2018年～2032年

第10章 中東・アフリカの動物用薬剤感受性検査市場の展望、2018年～2032年

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析